ResilienceAkashic RecordNCT07219914
This Study Explores the Mental Health Impact of Two Akashic Records Sessions.
A study testing Akashic Records Session in people with Resilience and Connectedness, run by Rasa Healing Inc at 1 site in United States.
Trial summary
The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, and to resilience (ability to bounce back) and feelings of connectedness (to self, community, and humanity). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Resilience, Connectedness, Depression
- What is being tested?
- Akashic Records Session
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 117 participants
- Where
- 1 siteUnited States
- Study dates
- 21 Jun 2024to 22 Jan 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18 years old and over
- Ability and willingness to provide written, informed consent in English prior to initiation of any study-related procedures and adhere to all study requirements
- Willingness to engage in discussion about past life patterns and emotions
- Self-report of anxiety, depressive or stress symptoms in the last 12 months
Who cannot join
- Inability to provide consent due to cognitive impairment, mental health disorders, or other conditions that impact their ability to understand the nature, risks, and benefits of the study.
- History of alcohol or substance use disorder within 12 months
- History of hypomania or psychotic episode within 12 months
- Prior history (lifetime diagnosis) of schizophrenia spectrum, or other psychotic disorders
- Experiencing any other serious mental or physical health issues that would impact their ability to engage in the research study
- Has either attempted suicide, has documented medical history of suicidal ideation, or been hospitalized due to suicide risk within 1 year prior to prescreening.
Show all 9Show fewer
- Previous Akashic Record Session with Interventionist, Candice S. Rasa, LCSW or previous Akashic Record Session with any other provider within 6 months.
- Any form of medicinal therapy should be stable 3 months prior to screening with no plan to start, stop or alter the use of any prescribed medications, supplements or other therapies from informed consent
- Any form of non-medical therapy should be stable 3 months prior to pre-screening with no plan to start, stop or alter use of psychotherapy, acupuncture, hypnosis, or other similar therapy from the time of providing informed consent.
Trial locations and contacts
1 site in 1 country.
United States1 site
Virtual/ No Physical Facility
Palm City, Florida, 34990
About this study
Official title: Akashic Records and Mental Health Outcomes
The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, and to resilience (ability to bounce back) and feelings of connectedness (to self, community, and humanity).
Main questions this study will answer are:
Read more
After two sessions, what is the impact on stress, anxiety, and depression? After two sessions, what is the impact on resilience and connectedness? How do participants describe their experience of the sessions? After two sessions, what are participants' views of their problems (insight), emotional experiences (impact) and observable behaviors in their daily life?
What participants will do:
Complete online surveys about their mood at four points: before the first session, before the second session, after the second session, and again 2 months later.
Surveys include:
DASS-21 (Depression, Anxiety, and Stress Scale) CD-RISC-10 (Connor-Davidson Resilience Scale) WATTS (Connectedness Scale) A short demographic form and satisfaction survey
Attend two individual Akashic Records sessions (50-90 minutes each) over private video platform with a licensed clinical social worker (principal investigator) The first 50 participants will also join a one-hour interview with open ended questions with a licensed clinical social worker (co-investigator) about one week after the second session to share their experience in their own words.
Who can take part:
Adults ages 18 and older who can read and consent in English and who have experienced stress, anxiety, or low mood in the past year.
How the research will happen:
Sessions are held by secure video call. Participants will also complete private online surveys before, during, and after the sessions. Some participants may be invited to share their experiences in a one-on-one interview. All information is kept private and names are removed before analysis.
Risks and benefits:
Talking about personal topics may bring up strong emotions. Licensed clinicians conduct sessions, offer support, and provide referrals if needed.
Possible benefits include new insights, greater peace or meaning, and improved coping; benefits are not guaranteed.
Why this matters:
Many people seek spiritual or transpersonal support for emotional concerns. This pilot study will provide early evidence on whether Akashic Records sessions may be a helpful, low-risk option and will guide future research.
Read the detailed description
The study aims to address the following research question: How do Akashic Records sessions impact mental health as evidenced by changes in self-reported stress, anxiety, and depression, and changes in resilience and connectedness?
This study is a single-arm, mixed-methods, exploratory pilot trial designed to evaluate the effects of Akashic Records sessions on mental health outcomes. The intervention consists of two individual sessions (one 90 minutes and one 50 minutes) delivered virtually by a licensed clinical social worker trained in Akashic Records channeling.
All participants are assigned to the same intervention arm consisting of two Akashic Records sessions; the study does not include randomization or a control/comparator group. To reduce potential confounding, participants are instructed to notify the research team of any changes in their mental health care or spiritual practices during the study period. They are also asked to maintain stability in their usual activities within these domains to support interpretability of pre-post outcomes.
The sessions follow a standardized structure to ensure reproducibility. Each session begins with an opening procedure that includes a brief Akashic prayer and a short reflection period for intention-setting. During the channeling process, the clinician conveys impressions received through intuitive modalities such as imagery (clairvoyance), auditory impressions (clairaudience), empathic resonance (clairsentience), and cognitive impressions (claircognizance). Information is verbalized in real time, and participants are invited to reflect, ask questions, and engage in dialogue to deepen integration. The clinician provides empathic support and reflective listening but does not apply structured psychotherapeutic interventions. Sessions conclude with a structured summary, identification of participant takeaways, and a formal closing statement.
The primary focus is on changes in validated clinical scales: the Depression, Anxiety, and Stress Scale (DASS-21), the Connor-Davidson Resilience Scale (CD-RISC-10), and the WATTS Connectedness Scale. Assessments are collected at four timepoints: baseline (T0), prior to the second session (T1), after the second session (T2), and 60 days following the intervention (T3).
In addition to quantitative endpoints, qualitative data are obtained from semi-structured interviews conducted with the first 50 participants until data saturation is reached. These interviews explore participant motivations, perceived benefits, integration of insights, and challenges. Transcripts are analyzed using structural and in vivo coding, followed by thematic analysis to generate emergent themes.
Approximately 100 adults will be enrolled, with inclusion criteria requiring age 18 or older, ability to provide informed consent, and willingness to engage in discussion of personal and emotional themes. Exclusion criteria include substance use disorder within the past 12 months, psychotic disorders, active suicidal ideation, or prior Akashic Records sessions within the past six months.
This research is conducted under expedited review and approval by Pearl IRB. Data are collected via HIPAA-compliant platforms (Jotform, Google Meet, and Dedoose), de-identified with unique participant IDs, and securely stored in encrypted systems.
The principal investigator will deliver all Akashic Records sessions but will not have access to raw survey data, qualitative transcripts, or primary statistical outputs, thereby reducing potential bias. The co-investigator will conduct prescreen interviews, review informed consent with participants, administer semi-structured interviews, and lead the qualitative analysis process with support from the independent research team. The research coordinator will manage participant communications, distribute validated clinical scales at designated timepoints, monitor adherence to study timelines, and ensure data is securely collected and logged.
This study is the first formal attempt to evaluate the Akashic Records in a structured clinical research design. Findings are intended to provide foundational evidence and inform the design of future controlled studies examining transpersonal and nonlocal interventions as potential contributors to mental health outcomes.
- Conditions
- Resilience, Connectedness, Depression, Anxiety, Stress
- Being tested
- Akashic Records Session
- Keywords
- mental health, anixety, depression, stress, resilience, connectedness, transpersonal psychology, spirituality, past lives, akashic records, akashic field, exploratory pilot study, altered states
- Medical subject headings
- Depression, Anxiety Disorders, Psychological Well-Being
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Akashic Records SessionBehavioural
Also called Akashic Channeling, Akashic Reading, Akashic Field Channeling
Participants will receive two individual Akashic Records sessions. The first session lasts 90 minutes and the second session lasts 50 minutes. Sessions are conducted virtually by a licensed clinician trained in Akashic channeling. Participants are encouraged to set intentions, receive channeled information, and reflect on insights
| Study group | Role | What they receive |
|---|---|---|
| Akashic Records Session Arm | Experimental | All participants receive two Akashic Records sessions: one 90-minute session and one 50-minute session, delivered virtually by a licensed clinician. Participants also complete validated clinical scales at baseline, post-session, and 60-day follow-up. Receives: Behavioral: Akashic Records Session |
What is being measured
The primary outcome is the main question the study is designed to answer.
DASS-21 (Depression, Anxiety, Stress) Clinical Scale
Change in participant self-reported depression, anxiety, and stress symptoms as measured by the DASS-21 (Depression, Anxiety, Stress Scale - 21 items). The DASS-21 has three subscales (Depression, Anxiety, Stress), each ranging from 0-42. Higher scores indicate greater symptom severity. Scores are calculated by summing responses (0 = "did not apply to me at all" to 3 = "applied very much/most of the time") and multiplying by two for comparability with the original 42-item scale. Analysis will compare baseline to post-intervention values across timepoints. The DASS-21 will be given to participants at 4 time points during the study.
Measured: T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session
Secondary outcomes (2)
CD-RISC-10 (Resilience) Clinical Scale
Change in participant self-reported resilience as measured by the CD-RISC-10 (Connor-Davidson Resilience Scale - 10 items). Scores range from 0-40, with higher scores indicating greater resilience (ability to adapt and bounce back from stress). Each item is scored 0 ("not true at all") to 4 ("true nearly all the time"). Total scores are calculated by summing item responses. Analysis will compare baseline to post-intervention values across timepoints. The CD-RISC-10 will be given to participants at 4 time points during the study.
Measured: T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session
WATTS Connectedness Scale
Change in participant self-reported connectedness as measured by the WATTS Connectedness Scale. This validated scale assesses three domains of connectedness: to self, to others, and to the wider world/humanity. Items are rated on a 0-100 scale, with higher scores indicating stronger connectedness. Total and subscale scores are calculated as means of item responses. Analysis will compare baseline to post-intervention values across timepoints. The WATTS will be given to participants at 4 time points during the study.
Measured: T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Oct 2025
- Study start21 Jun 2024
- Primary completion22 Nov 2025 (estimated)
- Study completion22 Jan 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for ResilienceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Single-arm pilot study: all participants receive two Akashic Records sessions (one 90-minute and one 50-minute) and complete validated clinical scales at baseline, post-session, and 60-day follow-up
- Masking
- None (open label)
- Enrolment
- 117 participants (actual)
Sponsor and investigators
- Lead sponsor
- Rasa Healing Inc
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Candice Rasa, LCSW, Rasa Healing Inc
- Investigators
- Candice S Rasa, LCSW, Principal investigator, Rasa Healing Inc
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07219914
- Sponsor's protocol ID
- #2024-0199
- Acronym
- Akashic Record
- Status last verified
- Oct 2025
- First submitted
- 18 Oct 2025
- Last updated
- 24 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No, individual participant data (IPD) will not be shared due to the sensitive nature of qualitative interviews and personal health information. Only de-identified, aggregated data will be accessible to research analysis personnel outside the core team (PI, Co-PI, and Research Coordinator). Published results and peer-reviewed articles will report only group-level findings and representative de-identified quotes, with no individual-level data disclosed.
Publications
Sheldrake R. An experimental test of the hypothesis of formative causation. Riv Biol. 1992;85(3-4):431-43.
PubMed 1341836Laszlo, E. (2007). Science and the Akashic Field: An Integral Theory of Everything. Inner Traditions.
Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008 Apr;31(2):180-91. doi: 10.1002/nur.20247.
PubMed 18183564Watts, R., et al. (2017). Patients' accounts of increased "connectedness" and "acceptance" after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology, 57(5), 520-564. https://doi.org/10.1177/0022167817709585
Rubik B, Muehsam D, Hammerschlag R, Jain S. Biofield Science and Healing: History, Terminology, and Concepts. Glob Adv Health Med. 2015 Nov;4(Suppl):8-14. doi: 10.7453/gahmj.2015.038.suppl. Epub 2015 Nov 1.
PubMed 26665037Brysbaert M. How Many Participants Do We Have to Include in Properly Powered Experiments? A Tutorial of Power Analysis with Reference Tables. J Cogn. 2019 Jul 19;2(1):16. doi: 10.5334/joc.72.
PubMed 31517234Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82. doi: 10.1002/da.10113.
PubMed 12964174
Study at a glance
From the registry record, last updated by the sponsor on 24 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Akashic Records and Mental Health Outcomes
- ClinicalTrials.gov ID
- NCT07219914
- Acronym / sponsor ID
- Akashic Record / #2024-0199
- Conditions
- Resilience, Connectedness, Depression, Anxiety, Stress
- Keywords
- mental health, anixety, depression, stress, resilience, connectedness, transpersonal psychology, spirituality
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 117 participants (actual)
- Lead sponsor
- Rasa Healing IncUniversity, hospital or other
- Study start
- 21 Jun 2024 (actual)
- Primary completion
- 22 Nov 2025 (estimated)
- Study completion
- 22 Jan 2026 (estimated)
- First posted
- 22 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, and to resilience (ability to bounce back) and feelings of connectedness (to self, community, and humanity).
Main questions this study will answer are:
After two sessions, what is the impact on stress, anxiety, and depression? After two sessions, what is the impact on resilience and connectedness? How do participants describe their experience of the sessions? After two sessions, what are participants' views of their problems (insight), emotional experiences (impact) and observable behaviors in their daily life?
What participants will do:
Complete online surveys about their mood at four points: before the first session, before the second session, after the second session, and again 2 months later.
Surveys include:
DASS-21 (Depression, Anxiety, and Stress Scale) CD-RISC-10 (Connor-Davidson Resilience Scale) WATTS (Connectedness Scale) A short demographic form and satisfaction survey
Attend two individual Akashic Records sessions (50-90 minutes each) over private video platform with a licensed clinical social worker (principal investigator) The first 50 participants will also join a one-hour interview with open ended questions with a licensed clinical social worker (co-investigator) about one week after the second session to share their experience in their own words.
Who can take part:
Adults ages 18 and older who can read and consent in English and who have experienced stress, anxiety, or low mood in the past year.
How the research will happen:
Sessions are held by secure video call. Participants will also complete private online surveys before, during, and after the sessions. Some participants may be invited to share their experiences in a one-on-one interview. All information is kept private and names are removed before analysis.
Risks and benefits:
Talking about personal topics may bring up strong emotions. Licensed clinicians conduct sessions, offer support, and provide referrals if needed.
Possible benefits include new insights, greater peace or meaning, and improved coping; benefits are not guaranteed.
Why this matters:
Many people seek spiritual or transpersonal support for emotional concerns. This pilot study will provide early evidence on whether Akashic Records sessions may be a helpful, low-risk option and will guide future research.
Detailed description
The study aims to address the following research question: How do Akashic Records sessions impact mental health as evidenced by changes in self-reported stress, anxiety, and depression, and changes in resilience and connectedness?
This study is a single-arm, mixed-methods, exploratory pilot trial designed to evaluate the effects of Akashic Records sessions on mental health outcomes. The intervention consists of two individual sessions (one 90 minutes and one 50 minutes) delivered virtually by a licensed clinical social worker trained in Akashic Records channeling.
All participants are assigned to the same intervention arm consisting of two Akashic Records sessions; the study does not include randomization or a control/comparator group. To reduce potential confounding, participants are instructed to notify the research team of any changes in their mental health care or spiritual practices during the study period. They are also asked to maintain stability in their usual activities within these domains to support interpretability of pre-post outcomes.
The sessions follow a standardized structure to ensure reproducibility. Each session begins with an opening procedure that includes a brief Akashic prayer and a short reflection period for intention-setting. During the channeling process, the clinician conveys impressions received through intuitive modalities such as imagery (clairvoyance), auditory impressions (clairaudience), empathic resonance (clairsentience), and cognitive impressions (claircognizance). Information is verbalized in real time, and participants are invited to reflect, ask questions, and engage in dialogue to deepen integration. The clinician provides empathic support and reflective listening but does not apply structured psychotherapeutic interventions. Sessions conclude with a structured summary, identification of participant takeaways, and a formal closing statement.
The primary focus is on changes in validated clinical scales: the Depression, Anxiety, and Stress Scale (DASS-21), the Connor-Davidson Resilience Scale (CD-RISC-10), and the WATTS Connectedness Scale. Assessments are collected at four timepoints: baseline (T0), prior to the second session (T1), after the second session (T2), and 60 days following the intervention (T3).
In addition to quantitative endpoints, qualitative data are obtained from semi-structured interviews conducted with the first 50 participants until data saturation is reached. These interviews explore participant motivations, perceived benefits, integration of insights, and challenges. Transcripts are analyzed using structural and in vivo coding, followed by thematic analysis to generate emergent themes.
Approximately 100 adults will be enrolled, with inclusion criteria requiring age 18 or older, ability to provide informed consent, and willingness to engage in discussion of personal and emotional themes. Exclusion criteria include substance use disorder within the past 12 months, psychotic disorders, active suicidal ideation, or prior Akashic Records sessions within the past six months.
This research is conducted under expedited review and approval by Pearl IRB. Data are collected via HIPAA-compliant platforms (Jotform, Google Meet, and Dedoose), de-identified with unique participant IDs, and securely stored in encrypted systems.
The principal investigator will deliver all Akashic Records sessions but will not have access to raw survey data, qualitative transcripts, or primary statistical outputs, thereby reducing potential bias. The co-investigator will conduct prescreen interviews, review informed consent with participants, administer semi-structured interviews, and lead the qualitative analysis process with support from the independent research team. The research coordinator will manage participant communications, distribute validated clinical scales at designated timepoints, monitor adherence to study timelines, and ensure data is securely collected and logged.
This study is the first formal attempt to evaluate the Akashic Records in a structured clinical research design. Findings are intended to provide foundational evidence and inform the design of future controlled studies examining transpersonal and nonlocal interventions as potential contributors to mental health outcomes.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Single-arm pilot study: all participants receive two Akashic Records sessions (one 90-minute and one 50-minute) and complete validated clinical scales at baseline, post-session, and 60-day follow-up
| Arm | Type | Receives |
|---|---|---|
| Akashic Records Session Arm | Experimental | Behavioral: Akashic Records SessionAll participants receive two Akashic Records sessions: one 90-minute session and one 50-minute session, delivered virtually by a licensed clinician. Participants also complete validated clinical scales at baseline, post-session, and 60-day follow-up. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- 18 years old and over
- Ability and willingness to provide written, informed consent in English prior to initiation of any study-related procedures and adhere to all study requirements
- Willingness to engage in discussion about past life patterns and emotions
- Self-report of anxiety, depressive or stress symptoms in the last 12 months
Key exclusion criteria (9 listed)
- Inability to provide consent due to cognitive impairment, mental health disorders, or other conditions that impact their ability to understand the nature, risks, and benefits of the study.
- History of alcohol or substance use disorder within 12 months
- History of hypomania or psychotic episode within 12 months
- Prior history (lifetime diagnosis) of schizophrenia spectrum, or other psychotic disorders
- Experiencing any other serious mental or physical health issues that would impact their ability to engage in the research study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Akashic Records SessionAlso: Akashic Channeling, Akashic Reading, Akashic Field ChannelingParticipants will receive two individual Akashic Records sessions. The first session lasts 90 minutes and the second session lasts 50 minutes. Sessions are conducted virtually by a licensed clinician trained in Akashic channeling. Participants are encouraged to set intentions, receive channeled information, and reflect on insights | Behavioural | Akashic Records Session Arm |
Primary outcome
DASS-21 (Depression, Anxiety, Stress) Clinical Scale
Time frame: T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session
Change in participant self-reported depression, anxiety, and stress symptoms as measured by the DASS-21 (Depression, Anxiety, Stress Scale - 21 items). The DASS-21 has three subscales (Depression, Anxiety, Stress), each ranging from 0-42. Higher scores indicate greater symptom severity. Scores are calculated by summing responses (0 = "did not apply to me at all" to 3 = "applied very much/most of the time") and multiplying by two for comparability with the original 42-item scale. Analysis will compare baseline to post-intervention values across timepoints. The DASS-21 will be given to participants at 4 time points during the study.
2 secondary outcomes
CD-RISC-10 (Resilience) Clinical Scale
Time frame: T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session
WATTS Connectedness Scale
Time frame: T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Oct 2025.
- Background: PubMed 1341836Sheldrake R. An experimental test of the hypothesis of formative causation. Riv Biol. 1992;85(3-4):431-43.
- BackgroundLaszlo, E. (2007). Science and the Akashic Field: An Integral Theory of Everything. Inner Traditions.
- Background: PubMed 18183564Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008 Apr;31(2):180-91. doi: 10.1002/nur.20247.
- BackgroundWatts, R., et al. (2017). Patients' accounts of increased "connectedness" and "acceptance" after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology, 57(5), 520-564. https://doi.org/10.1177/0022167817709585
- Background: PubMed 26665037Rubik B, Muehsam D, Hammerschlag R, Jain S. Biofield Science and Healing: History, Terminology, and Concepts. Glob Adv Health Med. 2015 Nov;4(Suppl):8-14. doi: 10.7453/gahmj.2015.038.suppl. Epub 2015 Nov 1.
- Background: PubMed 31517234Brysbaert M. How Many Participants Do We Have to Include in Properly Powered Experiments? A Tutorial of Power Analysis with Reference Tables. J Cogn. 2019 Jul 19;2(1):16. doi: 10.5334/joc.72.
- Background: PubMed 12964174Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82. doi: 10.1002/da.10113.
- Individual participant dataSharing planned: No. No, individual participant data (IPD) will not be shared due to the sensitive nature of qualitative interviews and personal health information. Only de-identified, aggregated data will be accessible to research analysis personnel outside the core team (PI, Co-PI, and Research Coordinator). Published results and peer-reviewed articles will report only group-level findings and representative de-identified quotes, with no individual-level data disclosed.
Related trials for Resilience
Not yet recruiting
"Family Resilience And Mind-body Enhancement" (FRAME): A Randomised Controlled Trial
Autism
Enrolling by invitationPhase 2
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
PSP - Progressive Supranuclear Palsy
Active, not recruitingObservational study
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections
Severe Mental Illness, Inflammation
Not yet recruiting
The Effect of Happiness Workshops on Nursing Students' Levels of Psychological Resilience
Psychological Resilience, Nursing Students
Recruiting
A Study Of Resilience And Mental Well-Being Through Breathing Practice For Clinical Care Professionals
Burnout, Healthcare Workers, Breathing Exercises
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Candice S Rasa, LCSW principal investigator
Rasa Healing Inc
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Akashic Records Session in people with Resilience and Connectedness, run by Rasa Healing Inc at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 24 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
DASS-21 (Depression, Anxiety, Stress) Clinical Scale (time frame: T0: Baseline and 7 days before 1st session (Session #1 is within 30 days of prescreen). T1: No more than 7 days before 2nd session (Session #2 is 10-21 days after 1st). T2: Within 7-14 days after 2nd session. T3: Within 60-80 days after 2nd session). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07219914, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2025.